BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1488880)

  • 1. Short-term effects of proparacaine on human corneal thickness.
    Herse P; Siu A
    Acta Ophthalmol (Copenh); 1992 Dec; 70(6):740-4. PubMed ID: 1488880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of corneal thickness after the instillation of topical anesthetics: proparacaine versus oxybuprocaine.
    Nam SM; Lee HK; Kim EK; Seo KY
    Cornea; 2006 Jan; 25(1):51-4. PubMed ID: 16331042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a proparacaine 0.50%-sodium fluorescein 0.25% mix and contact ultrasound pachymetry on central and midperipheral corneal thickness measured by noncontact optical pachymetry.
    Mukhopadhyay DR; North RV; Hamilton-Maxwell KE
    J Cataract Refract Surg; 2011 May; 37(5):907-13. PubMed ID: 21420274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of proparacaine on central corneal thickness values: an evaluation using noncontact specular microscopy and pentacam.
    Lam AK; Chen D
    Cornea; 2007 Jan; 26(1):55-8. PubMed ID: 17198014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizures following the use of proparacaine hydrochloride eye drops.
    Cydulka RK; Betzelos S
    J Emerg Med; 1990; 8(2):131-3. PubMed ID: 2362113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degree of corneal anaesthesia after topical application of 0.4% oxybuprocaine hydrochloride and 0.5% proparacaine hydrochloride ophthalmic solution in clinically normal cattle.
    Little WB; Jean GS; Sithole F; Little E; Jean KY
    Aust Vet J; 2016 Jun; 94(6):181-5. PubMed ID: 27237118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Regular/Dilute Proparacaine Anesthetic Eye Drops in Combination with Ophthalmic Antibiotics on Corneal Wound Healing.
    Zhang E; Gupta S; Olson E; Sinha PR; Hesemann NP; Fraunfelder FW; Mohan RR
    J Ocul Pharmacol Ther; 2022 Apr; 38(3):232-239. PubMed ID: 35275738
    [No Abstract]   [Full Text] [Related]  

  • 8. Duration of effect and effect of multiple doses of topical ophthalmic 0.5% proparacaine hydrochloride in clinically normal dogs.
    Herring IP; Bobofchak MA; Landry MP; Ward DL
    Am J Vet Res; 2005 Jan; 66(1):77-80. PubMed ID: 15691039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of corneal anesthesia following topical administration of 0.5% proparacaine hydrochloride solution in clinically normal cats.
    Binder DR; Herring IP
    Am J Vet Res; 2006 Oct; 67(10):1780-2. PubMed ID: 17014333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratitis from corneal anesthetic abuse after photorefractive keratectomy.
    Kim JY; Choi YS; Lee JH
    J Cataract Refract Surg; 1997 Apr; 23(3):447-9. PubMed ID: 9159692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of action of proparacaine and tetracaine topical ophthalmic formulations on corneal sensitivity in horses.
    Sharrow-Reabe KL; Townsend WM
    J Am Vet Med Assoc; 2012 Dec; 241(12):1645-9. PubMed ID: 23216041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal anesthetic effect and ocular tolerance of 3.5% lidocaine gel in comparison with 0.5% aqueous proparacaine and 0.5% viscous tetracaine in normal canines.
    Venturi F; Blocker T; Dees DD; Madsen R; Brinkis J
    Vet Ophthalmol; 2017 Sep; 20(5):405-410. PubMed ID: 27981712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corneal endothelial toxicity of topical anesthesia.
    Judge AJ; Najafi K; Lee DA; Miller KM
    Ophthalmology; 1997 Sep; 104(9):1373-9. PubMed ID: 9307629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal thickness values before and after oxybuprocaine 0.4% eye drops.
    Asensio I; Rahhal SM; Alonso L; Palanca-Sanfrancisco JM; Sanchis-Gimeno JA
    Cornea; 2003 Aug; 22(6):527-32. PubMed ID: 12883345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of duration of corneal anesthesia induced with ophthalmic 0.5% proparacaine hydrochloride by use of a Cochet-Bonnet aesthesiometer in clinically normal horses.
    Kalf KL; Utter ME; Wotman KL
    Am J Vet Res; 2008 Dec; 69(12):1655-8. PubMed ID: 19046014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of corneal hypesthesia on the duration of proparacaine anesthetic eyedrops.
    Weiss JS; Goren MB
    Am J Ophthalmol; 1991 Sep; 112(3):326-30. PubMed ID: 1882944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cooling proparacaine 0.5% eye drops on patient's comfort during instillation.
    Hu Youwei J; Chang B
    Eye (Lond); 2015 Aug; 29(8):1112-3. PubMed ID: 25907208
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical proparacaine abuse resulting in evisceration.
    Aksoy A; Başkan AM; Aslan L; Aslankurt M
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23608875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical bupivacaine and proparacaine: a comparison of toxicity, onset of action, and duration of action.
    Liu JC; Steinemann TL; McDonald MB; Thompson HW; Beuerman RW
    Cornea; 1993 May; 12(3):228-32. PubMed ID: 8500336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dilute topical proparacaine for pain relief after photorefractive keratectomy.
    Shahinian L; Jain S; Jager RD; Lin DT; Sanislo SS; Miller JF
    Ophthalmology; 1997 Aug; 104(8):1327-32. PubMed ID: 9261322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.